J Kyle Bohman1, Daryl J Kor2, Rahul Kashyap3, Ognjen Gajic3, Emir Festic4, Zhaoping He5, Augustine S Lee6. 1. Department of Anesthesia, Mayo Clinic College of Medicine, Rochester, MN. 2. Department of Anesthesia, Mayo Clinic College of Medicine, Rochester, MN; Multidisciplinary Epidemiology and Translational Research in Intensive Care Study Group, Division of Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN. 3. Multidisciplinary Epidemiology and Translational Research in Intensive Care Study Group, Division of Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN. 4. Department of Critical Care Medicine, Division of Pulmonary Medicine, Mayo Clinic College of Medicine, Jacksonville, FL. 5. Alfred I. duPont Hospital for Children, Wilmington, DE. 6. Department of Critical Care Medicine, Division of Pulmonary Medicine, Mayo Clinic College of Medicine, Jacksonville, FL. Electronic address: lee.augustine@mayo.edu.
Abstract
BACKGROUND: Airway pepsin has been increasingly used as a potentially sensitive and quantifiable biomarker for gastric-to-pulmonary aspiration, despite lack of validation in normal control subjects. This study attempts to define normal levels of airway pepsin in adults and distinguish between pepsin A (exclusive to stomach) and pepsin C (which can be expressed by pneumocytes). METHODS: We performed a prospective study of 51 otherwise healthy adult patients undergoing elective extremity orthopedic surgery at a single tertiary-care academic medical center. Lower airway samples were obtained immediately following endotracheal intubation and just prior to extubation. Total pepsin and pepsin A concentrations were directly measured by an enzymatic activity assay, and pepsin C was subsequently derived. Pepsinogen/pepsin C was confirmed by Western blot analyses. Baseline characteristics were secondarily compared. RESULTS: In all, 11 (22%; 95% CI = 9.9%-33%) had detectable airway pepsin concentrations. All 11 positive specimens had pepsin C, without any detectable pepsin A. Pepsinogen/pepsin C was confirmed by Western blot analyses. In a multivariate logistic regression, men were more likely to have airway pepsin (OR, 12.71, P = .029). CONCLUSIONS: Enzymatically active pepsin C, but not the gastric-specific pepsin A, is frequently detected in the lower airways of patients who otherwise have no risk for aspiration. This suggests that nonspecific pepsin assays should be used and interpreted with caution as a biomarker of gastropulmonary aspiration, as pepsinogen C potentially expressed from pneumocytes may be detected in airway samples.
BACKGROUND: Airway pepsin has been increasingly used as a potentially sensitive and quantifiable biomarker for gastric-to-pulmonary aspiration, despite lack of validation in normal control subjects. This study attempts to define normal levels of airway pepsin in adults and distinguish between pepsin A (exclusive to stomach) and pepsin C (which can be expressed by pneumocytes). METHODS: We performed a prospective study of 51 otherwise healthy adult patients undergoing elective extremity orthopedic surgery at a single tertiary-care academic medical center. Lower airway samples were obtained immediately following endotracheal intubation and just prior to extubation. Total pepsin and pepsin A concentrations were directly measured by an enzymatic activity assay, and pepsin C was subsequently derived. Pepsinogen/pepsin C was confirmed by Western blot analyses. Baseline characteristics were secondarily compared. RESULTS: In all, 11 (22%; 95% CI = 9.9%-33%) had detectable airway pepsin concentrations. All 11 positive specimens had pepsin C, without any detectable pepsin A. Pepsinogen/pepsin C was confirmed by Western blot analyses. In a multivariate logistic regression, men were more likely to have airway pepsin (OR, 12.71, P = .029). CONCLUSIONS: Enzymatically active pepsin C, but not the gastric-specific pepsin A, is frequently detected in the lower airways of patients who otherwise have no risk for aspiration. This suggests that nonspecific pepsin assays should be used and interpreted with caution as a biomarker of gastropulmonary aspiration, as pepsinogen C potentially expressed from pneumocytes may be detected in airway samples.
Authors: Norma A Metheny; Yie-Hwa Chang; Jing Song Ye; Sharon J Edwards; Julie Defer; Thomas E Dahms; Barbara J Stewart; Kathleen S Stone; Ray E Clouse Journal: Am J Crit Care Date: 2002-03 Impact factor: 2.228
Authors: Stephen Farrell; Cyril McMaster; David Gibson; Michael D Shields; William A McCallion Journal: J Pediatr Surg Date: 2006-02 Impact factor: 2.545
Authors: Samantha Decalmer; Rachel Stovold; Lesley A Houghton; Jeff Pearson; Chris Ward; Angela Kelsall; Helen Jones; Kevin McGuinness; Ashley Woodcock; Jaclyn A Smith Journal: Chest Date: 2012-10 Impact factor: 9.410
Authors: Steven Talbert; Annette M Bourgault; Kimberly Paige Rathbun; Bassam Abomoelak; Chirajyoti Deb; Devendra Mehta; Mary Lou Sole Journal: Am J Crit Care Date: 2021-11-01 Impact factor: 2.207
Authors: Steven Talbert; Christine Wargo Detrick; Kimberly Emery; Aurea Middleton; Bassam Abomoelak; Chirajyoti Deb; Devendra I Mehta; Mary Lou Sole Journal: Am J Crit Care Date: 2020-09-01 Impact factor: 2.228